CD44 and neoplasm: In an inducible melanoma model, driven by Cre activation in melanocytes via tamoxifen induction, immunization using 25 μg DNA, delivered by electroporation, resulted in delayed tumor growth, reduced tumor invasion depth in the skin, and increased infiltration of CD8+ T cells with an activated phenotype (CD44+ PD-1+) [61].